Tafenzi, H. A., Takniouine, Y. A., Choulli, F., Essadi, I., Belbaraka, R. (2026). Adjuvant (Ad) and neoadjuvant (NAd) strategies in higher risk hormone receptor–positive (HR+)/HER2-negative (HER2−) early breast cancer (EBC): Moroccan real-world outcomes.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e12735